Intrinsic Edge Capital Management’s Core Scientific CORZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.2M Hold
476,176
1.26% 25
2026
Q1
$7.12M Buy
476,176
+30,000
+7% +$512K 1.18% 28
2025
Q4
$6.5M Sell
446,176
-50,000
-10% -$872K 1.16% 41
2025
Q3
$8.9M Sell
496,176
-10,000
-2% -$147K 1.24% 30
2025
Q2
$8.64M Hold
506,176
1.21% 34
2025
Q1
$3.66M Hold
506,176
0.67% 49
2024
Q4
$7.11M Hold
506,176
0.86% 45
2024
Q3
$6M Sell
506,176
-222,000
-30% -$2.3M 0.73% 46
2024
Q2
$6.77M Buy
728,176
+628,176
+628% +$3.21M 0.61% 58
2024
Q1
$354K Buy
+100,000
New +$347K 0.03% 140

Other funds holding CORZ

Intrinsic Edge Capital Management's CORZ Position: Q2 2026 in Review

Intrinsic Edge Capital Management held its Core Scientific (CORZ) position steady in Q2 2026 at 476,176 shares worth $12.2M. The position accounts for 1.26% of the portfolio, ranked #25.

Intrinsic Edge Capital Management first reported a position in CORZ in Q1 2024 and has held it in 10 quarters since. 413 funds tracked by Wall St. Rank hold CORZ as of Q2 2026.

  • Intrinsic Edge Capital Management held 476,176 shares of Core Scientific worth $12.2M as of Q2 2026.
  • Intrinsic Edge Capital Management left its Core Scientific share count unchanged in Q2 2026.
  • Core Scientific made up 1.26% of Intrinsic Edge Capital Management's portfolio in Q2 2026, its #25 holding.
  • Intrinsic Edge Capital Management first reported a position in Core Scientific in Q1 2024 and has held it in 10 quarters since.
  • 413 funds tracked by Wall St. Rank held Core Scientific as of Q2 2026.

Based on Intrinsic Edge Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.